ENDOMETRIOID UTERINE CARCINOMA
Clinical trials for ENDOMETRIOID UTERINE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIOID UTERINE CARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIOID UTERINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug aims to shrink advanced tumors in early trial
Disease control Recruiting nowThis early-phase study tests an experimental drug called JNJ-89862175 in people with advanced solid tumors (lung, kidney, ovarian, or uterine cancers that have spread). The drug is designed to deliver a toxic payload directly to cancer cells. The main goals are to find a safe dos…
Matched conditions: ENDOMETRIOID UTERINE CARCINOMA
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New antibody drug targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called JNJ-87890387 in people with advanced solid tumors that have spread or cannot be removed. The drug is designed to help the immune system attack cancer cells. The main goals are to find a safe dose and to check for side effects. About …
Matched conditions: ENDOMETRIOID UTERINE CARCINOMA
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC